Effects of Mediterranean diet or Mindfulness-Based Stress Reduction during pregnancy on maternal gut and vaginal microbiota: a subanalysis of the Improving Mothers for a better PrenAtal Care Trial BarCeloNa (IMPACT BCN) trial
Por:
Selma-Royo, M, Crispi, F, Castro-Barquero, S, Casas, I, Larroya, M, Genero, M, Paules, C, Benitez, L, Youssef, L, Pascal, R, Encabo, N, Nakaki, A, Martín-Asuero, A, Oller-Guzmán, MT, Arranz, A, Vieta, E, Casas, R, Estruch, R, Gratacos, E, Collado, MC and Crovetto, F
Publicada:
1 oct 2025
Ahead of Print:
1 oct 2025
Resumen:
Background: Despite the importance of gestation period for human health, studies addressing the impact of maternal microbiota on its progression and its modulation by maternal lifestyle are scarce. Although most of the evidence in the field comes from observational studies, we recently described how some lifestyle interventions during pregnancy reduced the small-for-gestational-age (SGA) incidence. We hypothesized the pregnant individual's microbiome modulation as potential mechanism by which lifestyle interventions could impact gestation progression. Objectives: The objectives of this study was to investigate the effect of pregnancy lifestyle interventions, based on a Mediterranean dietary pattern (MD) or Stress Reduction program (SR) that proved to be beneficial in reducing the SGA incidence, on the pregnant individuals' gut and vaginal microbiota as exploratory outcomes. Methods: In a random subsample (n = 351) from a trial including pregnancies randomly allocated into an MD intervention, an SR program, or nonintervention, maternal fecal/vaginal samples were collected at the end of the interventions, and in a subset (n = 85) also at recruitment. Microbiota was profiled by 16S rRNA gene sequencing. Multivariate models evaluated the associations of microbiota with the interventions. Results: Mothers included in the study presented a similar gut microbiota profile before the intervention; pregnancy MD intervention influenced the overall structure of gut microbiota, (R2 = 0.008, F = 1.885, P = 0.002), which resulted in enrichment in Firmicutes phylum (Coeff = 0.06, 95% confidence interval [CI]: 0.002, 0.118), related to the increment in health-associated taxa(Lachnospiraceae/Ruminococcaceae families) and other SCFA producers; and diminishment in Campylobacter genus (Coeff =-0.91, 95% CI: -1.361, -0.459). The link of the SR program with gut microbiota was more limited; however, some key components from these families were also affected. Microbial diversity of gut microbiota decreased as pregnancy progressed, with this effect more observable in the mothers that followed the interventions. The interventions have a negligible association with the vaginal microbiota. Conclusions: Pregnancy lifestyle interventions influence maternal gut microbiota. The trial was registered at clinicaltrials.gov Identifier as NCT03166332. Clinical Trial Information: Date of Institutional Review Board approval and registration: 16 December 2016; 19 April 2017; Date of initial participant enrollment and date of first outcome (i.e., delivery of the pregnant individual enrolled): 1 February 2017; 10 May 2017.
Filiaciones:
Selma-Royo, M:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Crispi, F:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Ctr Biomed Res Rare Dis CIBER ER, Madrid, Spain
Castro-Barquero, S:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obes & Nutr CIBER, Madrid, Spain
Univ Barcelona, Inst Recerca Nutr Seguretat Alimentaria INSA UB, Barcelona, Spain
Casas, I:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Univ Barcelona, Fac Med & Ciencies Salut, Barcelona, Spain
Larroya, M:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Univ Barcelona, Fac Med & Ciencies Salut, Barcelona, Spain
Genero, M:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Recerca St Joan Deu IRSJD, Barcelona, Spain
Univ Barcelona, Fac Med & Ciencies Salut, Barcelona, Spain
Paules, C:
Inst Salud Carlos III ISCIII, Red Salud Materno Infantil & Desarrollo SAMID, Subdirecc Gen Evaluac & Fomento Invest, Inst Invest Sanitaria Aragon IISAragon,RETICS, Zaragoza, Spain
Fondo Europeo Desarrollo Reg FEDER, Zaragoza, Spain
Benitez, L:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Univ Barcelona, Fac Med & Ciencies Salut, Barcelona, Spain
:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Hosp Clin Barcelona, Josep Carreras Leukaemia Res Inst, Univ Barcelona Campus, Barcelona, Spain
Pascal, R:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Recerca St Joan Deu IRSJD, Barcelona, Spain
Inst Salud Carlos III, Madrid, Spain
Encabo, N:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Nakaki, A:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Oller-Guzmán, MT:
Inst esMindfulness, Barcelona, Spain
Arranz, A:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Vieta, E:
Univ Barcelona, Hosp Clin, Dept Psychiat & Psychol, Neurosci Inst,IDIBAPS,CIBERSAM, Barcelona, Spain
Casas, R:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obes & Nutr CIBER, Madrid, Spain
Univ Barcelona, Inst Recerca Nutr Seguretat Alimentaria INSA UB, Barcelona, Spain
Univ Barcelona, Dept Internal Med, Hosp Clin, Barcelona, Spain
Estruch, R:
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obes & Nutr CIBER, Madrid, Spain
Univ Barcelona, Inst Recerca Nutr Seguretat Alimentaria INSA UB, Barcelona, Spain
Univ Barcelona, Dept Internal Med, Hosp Clin, Barcelona, Spain
Gratacos, E:
Univ Barcelona, Hosp Clin, BCNatal, Barcelona, Spain
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Ctr Biomed Res Rare Dis CIBER ER, Madrid, Spain
Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
Inst Recerca St Joan Deu IRSJD, Barcelona, Spain
Collado, MC:
Inst Agrochem & Food Technol, Natl Res Council IATA CSIC, Paterna, Valencia, Spain
Crovetto, F:
Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Inst Recerca St Joan Deu IRSJD, Barcelona, Spain
Inst Salud Carlos III, Madrid, Spain
Green Submitted, hybrid
|